Who is sponsoring NCT04483024?

NCT04483024 is sponsored by Shan May Yong.

What drugs are being tested in NCT04483024?

Interventions in NCT04483024: Collagen hydrolysate and chicken extract.

What condition does NCT04483024 study?

NCT04483024 studies Knee Osteoarthritis, Muscle Loss.

Is NCT04483024 still recruiting?

NCT04483024 is currently completed. Last updated 29 July 2020.

Last reviewed 2020-07-29 · How we verify

NCT04483024

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of Chicken Extract and Collagen on Mobility

Completed Phase 1 Last updated 29 July 2020

What this trial tests

Phase 1 trial testing Collagen hydrolysate and chicken extract in Knee Osteoarthritis in 160 participants. Completed in 1 December 2019.

Timeline

1 December 2018

Primary endpoint
31 October 2019

1 December 2019

Quick facts

Lead sponsor	Shan May Yong
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	160
Start date	1 December 2018
Primary completion	31 October 2019
Estimated completion	1 December 2019
Sites	1 location across Taiwan

Drugs / interventions tested

Collagen hydrolysate and chicken extract

Conditions studied

Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
Muscle Loss — all drugs for Muscle Loss →

Sponsor

Shan May Yong

Who can join

Adults 45 to 75, any sex, with Knee Osteoarthritis or Muscle Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A randomized, double-blind placebo-controlled trial to study the effects of chicken extract and collagen on join, bone and muscle functions in comparison to an active comparator glucosamine

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Randomized, double-blind, four-arm pilot study on the effects of chicken essence and type II collagen hydrolysate on joint, bone, and muscle functions.
Chen CC, Chang SS, Chang CH, Hu CC, et al · · 2023 · cited 7× · PMID 36918892 · DOI 10.1186/s12937-023-00837-w
Randomized, Double-Blind, Four-Arm Pilot Study on the Effects of BRAND'S Chicken Essence and FlexC-II® on Joint, Bone, and Muscle Functions
Chen C, Chang S, Chang C, Hu C, et al · · 2020 · DOI 10.21203/rs.3.rs-126061/v1

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04483024 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Shan May Yong
Last refreshed: 29 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04483024.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing